@article{f05720d8fd134062a760b2d31786b5be,
title = "Editorial: trends in alcohol use and alcohol-associated liver disease in the US population—authors' reply",
author = "Singal, \{Ashwani K.\} and Arshad Arsalan and Winston Dunn and Arab, \{Juan P.\} and Wong, \{Robert J.\} and Kuo, \{Yong Fang\} and Kamath, \{Patrick S.\} and Shah, \{Vijay H.\}",
note = "Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article. Dr. Singal reports receiving personal fees from GiLead Pharma, non‐financial support from American Association for Study of Liver Diseases (AASLD), personal fees from American College of Gastroenterology (ACG), grants from ACG, grants from National Institute of Alcohol Abuse and Alcoholism, during the conduct of the study; grants from National Institute of Diabetes and Digestive and Kidney Diseases, personal fees from GiLead Pharmaceuticals, personal fees from Recordati Pharmaceuticals, personal fees from Alnylam Pharmaceuticals , personal fees from Medscape Gastroenterology, personal fees from Chronic Liver Disease Foundation, personal fees from Up‐to‐Date, non‐financial support from American Porphyria Foundation, outside the submitted work. 2",
year = "2021",
month = aug,
doi = "10.1111/apt.16520",
language = "English (US)",
volume = "54",
pages = "513--514",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "John Wiley and Sons Inc.",
number = "4",
}